2
-
Reslizumab
- Categories:
Categories, Drug Discovery & Development, Immunooncology, Inhibitors and Compound Libraries, Inhibitory Antibodies
$0.00 -
Secukinumab
- Categories:
Categories, Drug Discovery & Development, Immunooncology, Inhibitors and Compound Libraries, Inhibitory Antibodies
$0.00



